<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedBookArticle><BookDocument><PMID Version="1">31334958</PMID><ArticleIdList><ArticleId IdType="bookaccession">NBK544238</ArticleId></ArticleIdList><Book><Publisher><PublisherName>StatPearls Publishing</PublisherName><PublisherLocation>Treasure Island (FL)</PublisherLocation></Publisher><BookTitle book="statpearls">StatPearls</BookTitle><PubDate><Year>2022</Year><Month>01</Month></PubDate><BeginningDate><Year>2022</Year><Month>01</Month></BeginningDate><Medium>Internet</Medium></Book><ArticleTitle book="statpearls" part="article-27207">Piebaldism</ArticleTitle><Language>eng</Language><AuthorList Type="authors" CompleteYN="Y"><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Muneeb</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Penn State Health</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patton</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>San Antonio Uniformed Services Health Education Consortium</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zedek</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author></AuthorList><PublicationType UI="D000072643">Study Guide</PublicationType><Abstract><AbstractText>Piebaldism is an autosomal dominant disorder affecting melanocyte migration and development characterized by isolated congenital leukoderma (white skin) and poliosis (white hair) in a distinct ventral midline pattern. The most common cause of piebaldism is a mutation in the KIT proto-oncogene. However, researchers have identified other mutations. This mutation leads to abnormal melanocyte migration from the neural crest leading to leukoderma affecting the central forehead, central frontal scalp, mid-portion of the extremities, and central anterior trunk. Poliosis affecting a lock of hair just above the forehead is the most common finding in this disease. Histopathologic examination of the affected areas reveals an absence of melanocytes in the epidermis and hair follicles. If the diagnosis of piebaldism is suspected, a careful examination should take place to exclude overlapping syndromes with extra-cutaneous manifestations, such as Waardenburg syndrome. Although benign and isolated to the skin, piebaldism can be socially disabling for affected individuals. Treatment is targeted to improve cosmesis, including skin grafting, cell transplantation, camouflage techniques, and the use of hair dye for poliosis.</AbstractText><CopyrightInformation>Copyright © 2022, StatPearls Publishing LLC.</CopyrightInformation></Abstract><Sections><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s1">Continuing Education Activity</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s2">Introduction</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s3">Etiology</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s4">Epidemiology</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s5">Pathophysiology</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s6">Histopathology</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s7">History and Physical</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s8">Evaluation</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s9">Treatment / Management</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s10">Differential Diagnosis</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s11">Prognosis</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s12">Complications</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s13">Deterrence and Patient Education</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s14">Pearls and Other Issues</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s15">Enhancing Healthcare Team Outcomes</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s16">Review Questions</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27207" sec="article-27207.s17">References</SectionTitle></Section></Sections><ContributionDate><Year>2022</Year><Month>4</Month><Day>14</Day></ContributionDate><ReferenceList><Reference><Citation>Saleem MD. Biology of human melanocyte development, Piebaldism, and Waardenburg syndrome. Pediatr Dermatol. 2019 Jan;36(1):72-84.</Citation><ArticleIdList><ArticleId IdType="pubmed">30561083</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerra L, Primavera G, Raskovic D, Pellegrini G, Golisano O, Bondanza S, Kuhn S, Piazza P, Luci A, Atzori F, De Luca M. Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis. Br J Dermatol. 2004 Apr;150(4):715-21.</Citation><ArticleIdList><ArticleId IdType="pubmed">15099368</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S, Ojha A. Piebaldism: A brief report and review of the literature. Indian Dermatol Online J. 2012 May;3(2):144-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3481873</ArticleId><ArticleId IdType="pubmed">23130293</ArticleId></ArticleIdList></Reference><Reference><Citation>Grob A, Grekin S. Piebaldism in children. Cutis. 2016 Feb;97(2):90-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">26919497</ArticleId></ArticleIdList></Reference><Reference><Citation>Oiso N, Fukai K, Kawada A, Suzuki T. Piebaldism. J Dermatol. 2013 May;40(5):330-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">22670867</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas I, Kihiczak GG, Fox MD, Janniger CK, Schwartz RA. Piebaldism: an update. Int J Dermatol. 2004 Oct;43(10):716-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15485525</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu AE, Huang B, Li YW, Wang P, Shen H. Clinical, histopathological and ultrastructural characteristics of naevus depigmentosus. Clin Exp Dermatol. 2008 Jul;33(4):400-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">18355354</ArticleId></ArticleIdList></Reference><Reference><Citation>Neves DR, Régis Júnior JR, Oliveira PJ, Zac RI, Silveira Kde S. Melanocyte transplant in piebaldism: case report. An Bras Dermatol. 2010 May-Jun;85(3):384-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20676476</ArticleId></ArticleIdList></Reference><Reference><Citation>Njoo MD, Nieuweboer-Krobotova L, Westerhof W. Repigmentation of leucodermic defects in piebaldism by dermabrasion and thin split-thickness skin grafting in combination with minigrafting. Br J Dermatol. 1998 Nov;139(5):829-33.</Citation><ArticleIdList><ArticleId IdType="pubmed">9892949</ArticleId></ArticleIdList></Reference><Reference><Citation>Lommerts JE, Meesters AA, Komen L, Bekkenk MW, de Rie MA, Luiten RM, Wolkerstorfer A. Autologous cell suspension grafting in segmental vitiligo and piebaldism: a randomized controlled trial comparing full surface and fractional CO2 laser recipient-site preparations. Br J Dermatol. 2017 Nov;177(5):1293-1298.</Citation><ArticleIdList><ArticleId IdType="pubmed">28403523</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson MJ, Juhlin L. Epidermal sheet grafts for repigmentation of vitiligo and piebaldism, with a review of surgical techniques. Acta Derm Venereol. 1997 Nov;77(6):463-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9394984</ArticleId></ArticleIdList></Reference></ReferenceList></BookDocument><PubmedBookData><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31334958</ArticleId></ArticleIdList></PubmedBookData></PubmedBookArticle></PubmedArticleSet>
